| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.5 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.5 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.19 | 0.5 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |